These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 921089)

  • 41. Concurrent pemphigus and myasthenia gravis as manifestations of penicillamine toxicity.
    Jones E; Sobkowski WW; Murray SJ; Walsh NM
    J Am Acad Dermatol; 1993 Apr; 28(4):655-6. PubMed ID: 8463474
    [No Abstract]   [Full Text] [Related]  

  • 42. [Ocular myasthenia caused by D-penicillamine (author's transl)].
    Schmidt D; Kommerell G
    Klin Monbl Augenheilkd; 1976 Mar; 168(3):409-13. PubMed ID: 966573
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [3 cases of myasthenic syndrome induced by D-penicillamine].
    Derman H; Théron HP
    Bull Soc Ophtalmol Fr; 1987 Nov; 87(11):1235-6, 1241-3. PubMed ID: 3451832
    [No Abstract]   [Full Text] [Related]  

  • 44. [Penicillamine-induced myasthenia in chronic rheumatoid arthritis (author's transl)].
    Seitz D; Hopf HC; Janzen RW; Meyer W
    Dtsch Med Wochenschr; 1976 Jul; 101(31):1153-8. PubMed ID: 976101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [D-penicillamine induced myasthenic syndromes in rheumatoid arthritis. Two cases (author's transl)].
    Rodat O; Hamelin JP; Rossard A; Cottin S; Cler JM; Rodat G; Lemouroux P
    Nouv Presse Med; 1981 May; 10(20):1645-8. PubMed ID: 7255126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Undesirable effects of D-penicillamine in the therapy of rheumatoid arthritis].
    Trnavský K; Zbojanová M
    Fysiatr Revmatol Vestn; 1979 Apr; 57(2):87-91. PubMed ID: 570949
    [No Abstract]   [Full Text] [Related]  

  • 47. [Myasthenia gravis syndrome following administration of d-penicillamine (author's transl)].
    Rousseau JJ; Dieudonne LG
    Acta Neurol Belg; 1980; 80(3):165-73. PubMed ID: 7457085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Penicillamine-associated myasthenia gravis.
    Albers JW; Hodach RJ; Kimmel DW; Treacy WL
    Neurology; 1980 Nov; 30(11):1246-9. PubMed ID: 6252512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Myasthenic syndrome during treatment with D penicillamine. A recent case].
    Verret JM; Lignac N; Kahn MF
    Ann Med Interne (Paris); 1977; 128(6-7):557-60. PubMed ID: 921113
    [No Abstract]   [Full Text] [Related]  

  • 50. Multiple side effects of penicillamine therapy in one patient with rheumatoid arthritis.
    Essigman WK
    Ann Rheum Dis; 1982 Dec; 41(6):617-20. PubMed ID: 6216862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Myasthenia induced by penicillamine: does an interaction with tricyclic antidepressants exist?].
    Ferro J; Susano R; Gómez C; de Quirós JF
    Rev Clin Esp; 1993 Apr; 192(7):358-9. PubMed ID: 8497752
    [No Abstract]   [Full Text] [Related]  

  • 52. [Initiation of myasthentic reactions by means of d-penicillamine (author's transl1].
    Rosenberger K; Winter H; Adams AE
    Nervenarzt; 1978 May; 49(5):277-81. PubMed ID: 673084
    [No Abstract]   [Full Text] [Related]  

  • 53. Neuromuscular disorders associated with D-penicillamine treatment for rheumatoid arthritis.
    Devogelaer JP; Isaac G; Noël H; De Bruyère M; Huaux JP; Nagant de Deuxchaisnes C
    Int J Clin Pharmacol Res; 1985; 5(3):143-7. PubMed ID: 4018948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Penicillamine-induced ocular myasthenia gravis.
    O'Keefe M; Morley KD; Haining WM; Smith A
    Am J Ophthalmol; 1985 Jan; 99(1):66-7. PubMed ID: 3966521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-acetylcholine receptor antibodies in D-penicillamine-associated myasthenia gravis.
    Vincent A; Newsom-Davis J; Martin V
    Lancet; 1978 Jun; 1(8076):1254. PubMed ID: 78009
    [No Abstract]   [Full Text] [Related]  

  • 56. Role of penicillamine for the induction of myasthenia gravis.
    Smith CI; Hammarström L; Matell G; Nilsson BY
    Eur Neurol; 1983; 22(4):272-82. PubMed ID: 6884397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myasthenic pseudo-internuclear ophthalmoplegia due to penicillamine.
    George J; Spokes EG
    J Neurol Neurosurg Psychiatry; 1984 Sep; 47(9):1044. PubMed ID: 6481374
    [No Abstract]   [Full Text] [Related]  

  • 58. [Neuromuscular complications of D-penicillamine in rheumatoid arthritis].
    Dubost JJ; Soubrier M; Bouchet F; Kemeny JL; Lhopitaux R; Bussière JL; Sauvezie B
    Rev Neurol (Paris); 1992; 148(3):207-11. PubMed ID: 1604135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Myasthenic syndrome following oral treatment with penicillamine].
    François J; Verbraeken H; Gabriel P; Wille C
    Bull Soc Belge Ophtalmol; 1978; 182():126-30. PubMed ID: 756327
    [No Abstract]   [Full Text] [Related]  

  • 60. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.